These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 27383306)
21. Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer. Yang YC; Liu GJ; Yuan DF; Li CQ; Xue M; Chen LJ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1513-1519. PubMed ID: 30840273 [TBL] [Abstract][Full Text] [Related]
22. Arsenic sulfide reverses cisplatin resistance in non-small cell lung cancer in vitro and in vivo through targeting PD-L1. Tian W; Sun Y; Cheng Y; Ma X; Du W; Shi W; Guo Q Thorac Cancer; 2021 Oct; 12(19):2551-2563. PubMed ID: 34469060 [TBL] [Abstract][Full Text] [Related]
23. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1. Cheng R; Lu C; Zhang G; Zhang G; Zhao G Oncol Rep; 2017 Apr; 37(4):2129-2136. PubMed ID: 28350100 [TBL] [Abstract][Full Text] [Related]
25. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis. Chen L; Han X; Hu Z; Chen L Cancer Chemother Pharmacol; 2019 May; 83(5):921-931. PubMed ID: 30859368 [TBL] [Abstract][Full Text] [Related]
26. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p. Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948 [TBL] [Abstract][Full Text] [Related]
27. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway. Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099 [TBL] [Abstract][Full Text] [Related]
28. miR-125b-5p upregulation by TRIM28 induces cisplatin resistance in non-small cell lung cancer through CREB1 inhibition. Tan Q; Ma J; Zhang H; Wu X; Li Q; Zuo X; Jiang Y; Liu H; Yan L BMC Pulm Med; 2022 Dec; 22(1):469. PubMed ID: 36476351 [TBL] [Abstract][Full Text] [Related]
29. [Overexpression of miR-21 promotes proliferation and reduces apoptosis in non-small cell lung cancer]. Lan H; Lin CY; Yuan HY; Xiong B Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):742-6. PubMed ID: 22335905 [TBL] [Abstract][Full Text] [Related]
30. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1. Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-106a confers cisplatin resistance in non-small cell lung cancer A549 cells by targeting adenosine triphosphatase-binding cassette A1. Ma Y; Li X; Cheng S; Wei W; Li Y Mol Med Rep; 2015 Jan; 11(1):625-32. PubMed ID: 25339370 [TBL] [Abstract][Full Text] [Related]
32. [Role of SOX4 on DDP Resistance in Non-small Cell Lung Cancer Cell of A549]. Li W; Liu X; Zhang G; Zhang L Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):298-302. PubMed ID: 28532536 [TBL] [Abstract][Full Text] [Related]
33. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP). Wang Q; Zhong M; Liu W; Li J; Huang J; Zheng L Exp Lung Res; 2011 Sep; 37(7):427-34. PubMed ID: 21787234 [TBL] [Abstract][Full Text] [Related]
34. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8. Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821 [TBL] [Abstract][Full Text] [Related]
35. miR-150 modulates cisplatin chemosensitivity and invasiveness of muscle-invasive bladder cancer cells via targeting PDCD4 in vitro. Lei Y; Hu X; Li B; Peng M; Tong S; Zu X; Wang Z; Qi L; Chen M Med Sci Monit; 2014 Oct; 20():1850-7. PubMed ID: 25287716 [TBL] [Abstract][Full Text] [Related]
36. Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway. Liu ZL; Jin BJ; Cheng CG; Zhang FX; Wang SW; Wang Y; Wu B Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5370-5377. PubMed ID: 29243778 [TBL] [Abstract][Full Text] [Related]
37. Lidocaine alleviates cytotoxicity-resistance in lung cancer A549/DDP cells via down-regulation of miR-21. Yang Q; Zhang Z; Xu H; Ma C Mol Cell Biochem; 2019 Jun; 456(1-2):63-72. PubMed ID: 30644017 [TBL] [Abstract][Full Text] [Related]
38. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis. Cao L; Chen J; Ou B; Liu C; Zou Y; Chen Q Biomed Pharmacother; 2017 Sep; 93():570-579. PubMed ID: 28686971 [TBL] [Abstract][Full Text] [Related]
39. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer. Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319 [TBL] [Abstract][Full Text] [Related]
40. MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4. Ren W; Wang X; Gao L; Li S; Yan X; Zhang J; Huang C; Zhang Y; Zhi K Mol Cell Biochem; 2014 May; 390(1-2):253-62. PubMed ID: 24609942 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]